Rigel Pharmaceuticals Shares Outstanding 2006-2019 | RIGL

Rigel Pharmaceuticals shares outstanding from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Rigel Pharmaceuticals Annual Shares Outstanding
(Millions of Shares)
2018 161
2017 126
2016 94
2015 88
2014 88
2013 87
2012 75
2011 63
2010 53
2009 41
2008 36
2007 29
2006 25
2005 22
Rigel Pharmaceuticals Quarterly Shares Outstanding
(Millions of Shares)
Q3 2019 168
Q2 2019 167
Q1 2019 167
Q4 2018 161
Q3 2018 166
Q2 2018 162
Q1 2018 147
Q4 2017 126
Q3 2017 125
Q2 2017 123
Q1 2017 114
Q4 2016 94
Q3 2016 95
Q2 2016 92
Q1 2016 91
Q4 2015 88
Q3 2015 89
Q2 2015 88
Q1 2015 88
Q4 2014 88
Q3 2014 88
Q2 2014 88
Q1 2014 88
Q4 2013 87
Q3 2013 87
Q2 2013 87
Q1 2013 87
Q4 2012 75
Q3 2012 72
Q2 2012 71
Q1 2012 71
Q4 2011 63
Q3 2011 71
Q2 2011 58
Q1 2011 52
Q4 2010 53
Q3 2010 53
Q2 2010 53
Q1 2010 52
Q4 2009 41
Q3 2009 38
Q2 2009 37
Q1 2009 37
Q4 2008 36
Q3 2008 37
Q2 2008 37
Q1 2008 34
Q4 2007 29
Q3 2007 31
Q2 2007 28
Q1 2007 25
Q4 2006 25
Q3 2006 25
Q2 2006 25
Q1 2006 25
Q4 2005 22
Q3 2005 23
Q2 2005 20
Q1 2005 20
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.380B $0.045B
Rigel Pharmaceuticals, Inc. is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases. Its goal is to file one new investigative new drug application in a significant indication each year. The Company's pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market our product candidates. We have product development programs in inflammatory/autoimmune diseases such as rheumatoid arthritis, thrombocytopenia, and asthma and allergy, as well as in cancer.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $61.158B 9.66
Zoetis (ZTS) United States $55.822B 33.39
Astellas Pharma (ALPMY) Japan $32.413B 15.44
Eisai (ESALY) Japan $19.472B 37.55
Merck (MKGAF) Germany $15.591B 21.27
Grifols, S.A (GRFS) Spain $14.693B 18.75
UCB SA (UCBJF) Belgium $14.669B 0.00
Neurocrine Biosciences (NBIX) United States $10.259B 484.35
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
IPSEN SA ADR (IPSEY) France $9.028B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.638B 0.00
Ionis Pharmaceuticals (IONS) United States $8.015B 16.23
Jazz Pharmaceuticals (JAZZ) Ireland $7.486B 9.56
Sage Therapeutics (SAGE) United States $7.312B 0.00
Catalent (CTLT) United States $7.236B 29.44
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.214B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Hypermarcas (HYPMY) Brazil $5.267B 18.93
Arrowhead Pharmaceuticals (ARWR) United States $4.293B 98.42
United Therapeutics (UTHR) United States $3.930B 0.00
Nektar Therapeutics (NKTR) United States $3.579B 0.00
Evotec AG (EVTCY) Germany $3.212B 52.56
FibroGen (FGEN) United States $3.091B 91.18
Taro Pharmaceutical Industries (TARO) Israel $2.934B 10.72
PTC Therapeutics (PTCT) United States $2.574B 0.00
Portola Pharmaceuticals (PTLA) United States $2.154B 0.00
Tilray (TLRY) Canada $2.106B 0.00
Xencor (XNCR) United States $1.972B 59.94
Zogenix (ZGNX) United States $1.963B 0.00
Corcept Therapeutics (CORT) United States $1.841B 22.38
Pacira Pharmaceuticals (PCRX) United States $1.788B 52.89
Ironwood Pharmaceuticals (IRWD) United States $1.780B 56.75
Heron Therapeutics (HRTX) United States $1.655B 0.00
USANA Health Sciences (USNA) United States $1.610B 17.18
CLINIGEN GP (CLIGF) United Kingdom $1.244B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.212B 19.99
Radius Health (RDUS) United States $1.161B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.977B 0.00
Karyopharm Therapeutics (KPTI) United States $0.969B 0.00
ArQule (ARQL) United States $0.953B 0.00
Endo (ENDP) Ireland $0.938B 1.72
Spectrum Pharmaceuticals (SPPI) United States $0.915B 0.00
Aerie Pharmaceuticals (AERI) United States $0.875B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.808B 5.51
TherapeuticsMD (TXMD) United States $0.740B 0.00
Organogenesis Holdings (ORGO) United States $0.711B 0.00
Collegium Pharmaceutical (COLL) United States $0.642B 0.00
Flexion Therapeutics (FLXN) United States $0.609B 0.00
Translate Bio (TBIO) United States $0.565B 0.00
ChemoCentryx (CCXI) United States $0.559B 0.00
Concordia (CXRXF) Canada $0.552B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.506B 61.38
ImmunoGen (IMGN) United States $0.482B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.472B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.458B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.454B 0.00
Dermira (DERM) United States $0.441B 0.00
Siga Technologies (SIGA) United States $0.412B 9.41
Akebia Therapeutics (AKBA) United States $0.396B 0.00
Indivior (INVVY) United States $0.390B 1.41
DURECT (DRRX) United States $0.385B 0.00
OptiNose (OPTN) United States $0.383B 0.00
Recro Pharma (REPH) United States $0.383B 0.00
Ardelyx (ARDX) United States $0.381B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.374B 16.14
Innate Pharma SA (IPHYF) France $0.372B 0.00
Lannett Co Inc (LCI) United States $0.362B 4.22
Harpoon Therapeutics (HARP) United States $0.324B 0.00
Molecular Templates (MTEM) United States $0.323B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.282B 0.00
GlycoMimetics (GLYC) United States $0.258B 0.00
Rafael Holdings (RFL) United States $0.244B 0.00
Xeris Pharmaceuticals (XERS) United States $0.221B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.208B 0.00
KalVista Pharmaceuticals (KALV) United States $0.200B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.198B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.187B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.182B 0.00
Nature's Sunshine Products (NATR) United States $0.181B 31.23
MARKER THERAPEUTICS, INC (MRKR) United States $0.179B 0.00
Concert Pharmaceuticals (CNCE) United States $0.176B 0.00
Calithera Biosciences (CALA) United States $0.167B 0.00
Jounce Therapeutics (JNCE) United States $0.164B 2.19
Taiwan Liposome (TLC) Taiwan $0.163B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.153B 0.00
CV Sciences (CVSI) United States $0.152B 0.00
Aquestive Therapeutics (AQST) United States $0.144B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.142B 0.00
CannTrust Holdings (CTST) Canada $0.139B 0.00
MEI Pharma (MEIP) United States $0.138B 0.00
Redhill Biopharma (RDHL) Israel $0.134B 0.00
IMV INC (IMV) Canada $0.131B 0.00
Ocular Therapeutix (OCUL) United States $0.121B 0.00
Cardiome Pharma (CORV) Canada $0.119B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.096B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.089B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.087B 25.77
Neos Therapeutics (NEOS) United States $0.079B 0.00
Majesco Entertainment (PTE) United States $0.078B 0.00
MediWound (MDWD) Israel $0.078B 0.00
Otonomy (OTIC) United States $0.077B 0.00
Aclaris Therapeutics (ACRS) United States $0.075B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.073B 0.00
Generex Biotechnology (GNBT) United States $0.069B 0.00
SCYNEXIS (SCYX) United States $0.067B 0.00
Champions Oncology (CSBR) United States $0.065B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.063B 0.00
Natural Alternatives (NAII) United States $0.063B 9.55
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.059B 0.00
Medicure (MCUJF) Canada $0.058B 0.00
Novan (NOVN) United States $0.057B 0.00
Genocea Biosciences (GNCA) United States $0.056B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.056B 0.00
Pharmaxis (PXSLY) Australia $0.055B 0.00
RENEURON GP (RNUGF) United Kingdom $0.054B 0.00
IntelGenx Technologies (IGXT) Canada $0.054B 0.00
AgeX Therapeutics (AGE) United States $0.054B 0.00
ElectroCore (ECOR) United States $0.054B 0.00
Infinity Pharmaceuticals (INFI) United States $0.052B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.048B 0.00
Jaguar Animal Health (JAGX) United States $0.046B 0.00
Nivalis Therapeutics (ALPN) United States $0.045B 0.00
Capnia (SLNO) United States $0.045B 0.00
CTI BioPharma (CTIC) United States $0.044B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.042B 0.00
Forward Pharma (FWP) Denmark $0.042B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.040B 0.00
Mannatechorporated (MTEX) United States $0.037B 0.00
Opexa Therapeutics (ACER) United States $0.034B 0.00
India Globalization Capital (IGC) United States $0.034B 0.00
Iterum Therapeutics (ITRM) Ireland $0.034B 0.00
Mast Therapeutics (SVRA) United States $0.032B 0.00
Bio-Path Holdings (BPTH) United States $0.031B 0.00
Biomerica (BMRA) United States $0.030B 0.00
Melinta Therapeutics (MLNT) United States $0.028B 0.00
PharmAthene (ALT) United States $0.027B 0.00
China SXT Pharmaceuticals (SXTC) China $0.025B 0.00
IsoRay (ISR) United States $0.023B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Lipocine (LPCN) United States $0.020B 0.00
Flex Pharma (SLRX) United States $0.016B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.016B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.016B 0.00
Cyanotech (CYAN) United States $0.015B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Heat Biologics (HTBX) United States $0.014B 0.00
Shineco (TYHT) China $0.014B 17.17
Regulus Therapeutics (RGLS) United States $0.014B 0.00
HANCOCK JAFFE (HJLI) United States $0.011B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.008B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
Achieve Life Sciences (ACHV) United States $0.008B 0.00
RXi Pharmaceuticals (PHIO) United States $0.007B 0.00
Vical (BBI) United States $0.007B 0.00
VAXART, INC (VXRT) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Midatech Pharma (MTP) United Kingdom $0.003B 0.00
Onconova Therapeutics (ONTX) United States $0.002B 0.00
Hemispherx BioPharma (AIM) United States $0.002B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00